实用药物与临床
實用藥物與臨床
실용약물여림상
PRACTICAL PHARMACY AND CLINICAL REMEDIES
2015年
8期
990-992,993
,共4页
姜彩霞%麻莉%海宁%田彩霞
薑綵霞%痳莉%海寧%田綵霞
강채하%마리%해저%전채하
宫腔粘连%再发粘连%雌激素%月经改善%不良反应
宮腔粘連%再髮粘連%雌激素%月經改善%不良反應
궁강점련%재발점련%자격소%월경개선%불량반응
Intrauterine adhesions%Recurrent adhesions%Estrogen%Menstrual improvement%Adverse reactions
目的:探讨宫腔粘连术后预防再发粘连的药物应用方法与效果。方法重度宫腔粘连患者240例,根据随机抽签法分为治疗组120例与对照组120例,所有患者都给予宫腔粘连分离术,治疗组术后口服雌激素,对照组术后未服用雌激素,术后随访1年。结果经过随访调查,宫腔粘连术后,对照组宫腔再粘连率约为27.5%,治疗组为5.0%,治疗组预防再发粘连的效果显著优于对照组(P<0.05)。宫腔粘连术后,治疗组月经改善率为90.8%,对照组为61.7%,治疗组术后月经改善率明显高于对照组( P<0.05)。两组术后乳房胀痛、胃肠道反应、阴道不规则出血、肝肾功能损害等不良反应情况比较差异无统计学意义( P>0.05)。治疗组的妊娠率与分娩率分别为55.8%和25.8%,而对照组分别为27.5%和11.7%,治疗组的妊娠率与分娩率明显高于对照组(P<0.05)。结论宫腔粘连术后口服雌激素能有效预防术后粘连的发生,安全性好,能改善月经状况,从而提高术后妊娠率与分娩率。
目的:探討宮腔粘連術後預防再髮粘連的藥物應用方法與效果。方法重度宮腔粘連患者240例,根據隨機抽籤法分為治療組120例與對照組120例,所有患者都給予宮腔粘連分離術,治療組術後口服雌激素,對照組術後未服用雌激素,術後隨訪1年。結果經過隨訪調查,宮腔粘連術後,對照組宮腔再粘連率約為27.5%,治療組為5.0%,治療組預防再髮粘連的效果顯著優于對照組(P<0.05)。宮腔粘連術後,治療組月經改善率為90.8%,對照組為61.7%,治療組術後月經改善率明顯高于對照組( P<0.05)。兩組術後乳房脹痛、胃腸道反應、陰道不規則齣血、肝腎功能損害等不良反應情況比較差異無統計學意義( P>0.05)。治療組的妊娠率與分娩率分彆為55.8%和25.8%,而對照組分彆為27.5%和11.7%,治療組的妊娠率與分娩率明顯高于對照組(P<0.05)。結論宮腔粘連術後口服雌激素能有效預防術後粘連的髮生,安全性好,能改善月經狀況,從而提高術後妊娠率與分娩率。
목적:탐토궁강점련술후예방재발점련적약물응용방법여효과。방법중도궁강점련환자240례,근거수궤추첨법분위치료조120례여대조조120례,소유환자도급여궁강점련분리술,치료조술후구복자격소,대조조술후미복용자격소,술후수방1년。결과경과수방조사,궁강점련술후,대조조궁강재점련솔약위27.5%,치료조위5.0%,치료조예방재발점련적효과현저우우대조조(P<0.05)。궁강점련술후,치료조월경개선솔위90.8%,대조조위61.7%,치료조술후월경개선솔명현고우대조조( P<0.05)。량조술후유방창통、위장도반응、음도불규칙출혈、간신공능손해등불량반응정황비교차이무통계학의의( P>0.05)。치료조적임신솔여분면솔분별위55.8%화25.8%,이대조조분별위27.5%화11.7%,치료조적임신솔여분면솔명현고우대조조(P<0.05)。결론궁강점련술후구복자격소능유효예방술후점련적발생,안전성호,능개선월경상황,종이제고술후임신솔여분면솔。
Objective To investigate the effects of estrogen on recurrent postoperative intrauterine adhe-sions. Methods 240 patients with severe intrauterine adhesions were equally randomly divided into treatment group (n=120) and control group (n =120),all the patients were given intrauterine adhesions dissection,and treatment group received oral estrogen after operation. All the patients were followed up for 1 year. Results In the followed-up survey, the postoperative adhesions recurrence in treatment group was lower than that of control group ( 5. 0%vs. 27. 5%,P <0. 05 ) . The menstrual improvement rate in treatment group was higher than that of control group (90. 8% vs. 61. 7%,P<0. 05). There was no significant difference in postoperative breast pain,gastrointestinal reac-tions,abnormal vaginal bleeding,liver and kidney dysfunction and other adverse reactions between the two groups ( P>0. 05) . The pregnancy and delivery rates of treatment group were higher than those of control group ( 55. 8%vs. 27. 5%,25. 8% vs. 11. 7%, P <0. 05 ) . Conclusion Estrogen could prevent the postoperative intrauterine adhe-sions with good safety,it can improve menstrual status,thereby increase the rates of postoperative pregnancy and child-birth.